PubRank

Valerie Waters

Author PubWeight™ 17.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Health benefits of dietary fiber. Nutr Rev 2009 3.54
2 Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners. Can J Infect Dis Med Microbiol 2006 1.81
3 Sputum induction in routine clinical care of children with cystic fibrosis. J Pediatr 2010 1.67
4 Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States. Pediatr Infect Dis J 2009 1.52
5 Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients. Antimicrob Agents Chemother 2013 0.98
6 Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis. J Cyst Fibros 2012 0.96
7 Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis. Transplantation 2014 0.82
8 Epidemiology of borderline oxacillin-resistant Staphylococcus aureus in pediatric cystic fibrosis. Pediatr Pulmonol 2011 0.81
9 Invasive aspergillosis in cystic fibrosis: a fatal case in an adolescent and review of the literature. Pediatr Infect Dis J 2011 0.81
10 Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients. J Antimicrob Chemother 2007 0.80
11 Serum galactomannan in cystic fibrosis patients colonized with Aspergillus species. Med Mycol 2012 0.79
12 Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. Cochrane Database Syst Rev 2014 0.78
13 Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients. J Cyst Fibros 2013 0.78
14 Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. Cochrane Database Syst Rev 2012 0.76
15 An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis. BMC Pulm Med 2015 0.76
16 Optimizing Blood Collection and Processing for QuantiFERON-TB Gold-In Tube Testing Gives Low Rates of Indeterminate Results: Clinical Implications. Pediatr Infect Dis J 2017 0.75
17 Infections With Biofilm Formation: Selection of Antimicrobials and Role of Prolonged Antibiotic Therapy. Pediatr Infect Dis J 2016 0.75
18 Incompatibility of ciprofloxacin and meropenem injections. Am J Health Syst Pharm 2013 0.75
19 Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis. Cochrane Database Syst Rev 2016 0.75